239000011780 sodium chloride Substances 0.000 claims description 78.102000004965 antibodies Human genes 0.000 claims description 85.229920001850 Nucleic acid sequence Polymers 0.000 claims description 126.229920003013 deoxyribonucleic acid Polymers 0.000 claims description 299.239000003795 chemical substances by application Substances 0.000 claims abstract description 41.125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 306.108090000623 proteins and genes Proteins 0.000 claims abstract description 331.102000004169 proteins and genes Human genes 0.000 claims abstract description 332.230000003908 liver function Effects 0.000 title claims abstract description 55.Publication of WO2000071151A1 publication Critical patent/WO2000071151A1/en Links filed Critical Takeda Chemical Industries, Ltd. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to JP11/141106 priority Critical Priority to JP14110699 priority Priority to JP2000014044 priority Priority to JP2000/14044 priority Application filed by Takeda Chemical Industries, Ltd. Priority date (The priority date is an assumption and is not a legal conclusion. Inventor Hideki Matsui Ysushi Shintani Yukiko Hikichi Original Assignee Takeda Chemical Industries, Ltd. Google Patents WO2000071151A1 - Liver function controlling agents These specifications are located in "Orders and Results Anywhere".WO2000071151A1 - Liver function controlling agents Note: Performing labs which are active participants in the Orders and Results Anywhere network use an interface that adheres to the same guidelines but has context aware connectivity to its consistituent ordering organizations without the need for a VPN or TCP/IP connection.
Use the LRI format unless you have a specific need to use the ELR or NAACCR formatted results. These messages conform to the North American Association of Central Cancer Registries (NAACCR) Standards for Cancer Registries Volume V rules for constructing HL7 messages for CAP electronic cancer checklist synoptic reporting. This interface can send messages for pathology reports that contain electronic cancer checklists.This format is often used to notify public health agencies of tests which must be reported for disease tracking, and meet Meaningful Use (MU) or Promoting Interoperability (PI) measures in the U.S. ELR format results follow the HL7 version 2.5.1 Implementation Guide: Electronic Laboratory Reporting to Public Health, Release 1. This interface can send result messages in the ELR format.It can send both order status and result messages from Beaker to external systems, when Beaker is the reference lab for another LIS or clinical system. LRI format results follow the HL7 version 2.5.1 Implementation Guide: S&I Framework Lab Results Interface, Release 1. This interface can send result messages in the LRI format.You can configure each copy of this interface one of the following ways: IRIS (Intelligent Retinal Imaging Systems).Outgoing Provider Communications Interface Rochester Regional Health Information Organization.North Carolina Health Information Exchange Authority.North Carolina - Public Health Agencies.Great Lakes Health Information Exchange.Gateway Electronic Medical Management Systems.Denver County (CO) - Public Health Agencies.Chesapeake Regional Information System for Our Patients.Bronx Regional Health Information Organization.Arkansas Office of Health Information Technology.
0 kommentar(er)
